Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol in Laparoscopic Cholecystectomy
NCT05164159Completed
- Sponsor
- Yonsei University
- Start
- Feb 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in acute cholecystitis (2 arms), sponsored by Yonsei University. Primary endpoint: Percent of patients with hypotension event. Started Feb 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
acute cholecystitis
Beyond the preview
Go deeper on NCT05164159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05164159.